在晚期心力衰竭中进行三管吐的透导管程序:系统性审查
Christos Kourek1, Serge Sicouri2, Dimitrios E Magouliotis2
1Department of Cardiology, 417 Army Share Fund Hospital of Athens (NIMTS), Athens, Greece.
Trends in cardiovascular medicine
|October 24, 2025
概括
过导管三回 (TR) 治疗可以改善晚期心力衰竭 (HF) 患者的症状和功能. 这些最小侵入性的选择为高风险个体的TR管理提供了有希望的结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏衰竭管理的管理
背景情况:
- 三管吐 (TR) 在晚期心力衰竭 (HF) 中显著恶化预后和功能能力.
- 在高风险的HF患者中管理TR,由于并发症和高手术风险,这就提出了临床挑战.
研究的目的:
- 系统地审查和综合基于跨导管器件的三管干预措施的证据,用于高级高频率的TR.
- 评估与这些新型疗法相关的程序结果,生存率和功能改善.
主要方法:
- 在主要的生物医学数据库 (PubMed,Embase,Scopus,CINAHL,Cochrane Library) 进行了全面的文献搜索.
- 包括的研究集中在中度至重度TR的中导管手术中,在晚期HF患者中,报告了关键临床终点.
- 分析了37项涉及约2372名患者的研究数据,涵盖了各种设备类型.
主要成果:
- 过导管干预表明了高的程序成功率,显著降低了TR的严重程度.
- 患者在NYHA课程,6分钟步行距离和生活质量方面经历了显著的改善.
- 边缘到边缘修复设备经常被研究,显示出良好的安全性和症状缓解,尽管长期死亡率数据仍然有限.
结论:
- 对于晚期HF的TR进行过导管干预是有效的改善症状,功能状态和生活质量.
- 这些微创方法为不适合手术的高风险患者提供了可行的替代方案.
- 个性化治疗策略至关重要,因为患者的个人资料和解剖学变异的异质性.
相关概念视频
Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
402
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
402
Cardiac Catheterization III: Left Heart Catheterization
572
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
572
Cardiac Catheterization I: Pre-Procedure Overview
1.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.1K


